T-lymphotropic virus type-I in patients with tropical spastic
paraparesis. Lancet 1985;ii:407–10.
3. ROMA ́ N GC. The neuroepidemiology of tropical spastic 25.
paraparesis. Ann Neurol 1988;23(suppl):S113–S130.
4. GESSAIN A, GOUT O. Chronic myelopathy associated with
human T-lymphotropic virus type I (HTLV-I). Ann Intern
Med 1992;117:933–46.
5. HO ̈ LLSBERG P, HAFLER DA. Pathogenesis of diseases induced 26.
by human lymphotropic virus type I infection. N Engl J
Med 1993;328:1173–82.
6. ROMA ́ N GC, NAVARRO-ROMA ́ N L, OSAME M. Human lymphotropic virus type I neurotropism. Prog Med Virol 1990;37: 27.
190–210.
7. REEVES WC. The epidemiology of human T-lymphotropic 28.
virus type I in Panama. In: BLATTNER WA, ed. Human
Retrovirology: HTLV-I, New York: Raven Press Ltd., 1990. 29.
8. LEVINE PH, REEVES WC, CUEVAS M et al. Human T-lymphotropic virus type I and hematologic malignancies in 30.
Panama. Cancer 1989;63:2186–91.
9. GRACIA F, REEVES WC, LEVINE PH et al. Human T-lymphotropic virus type I and neurologic disease in Panama 1985 and 31.
1986. Arch Neurol 1990;47:634–9.
10. ROMA ́ N GC, VERNANT JC, OSAME M, eds. HTLV-I and the
32.
nervous system. New York: Alan R. Liss, 1989.
11. DICKOFF DJ, SIMPSON DM, WILEY CA et al. HTLV-1 in
acquired adult myopathy. Muscle Nerve 1993;16:162–5.
12. GABBAI AA, WILEY CA, OLIVEIRA ASB et al. Skeletal muscle
33.
involvement in tropical spastic paraplegia/HTLV-1-associated myelopathy. Muscle Nerve 1994;17:923–30.
13. LUDOLPH AC, HUGON J, ROMA ́ N GC et al. A clinical neuro-34.
physiologic study of tropical spastic paraparesis. Muscle
Nerve 1988;11:392–7.
14. MORGAN OS, RODGERS-JOHNSON P, MORA C et al. HTLV-I and
35.
polymyositis in Jamaica. Lancet 1989;2:1184–7.
15. ROMA ́ N GC, VERNANT JC, OSAME M. HTLV-I-associated
36.
motor neuron disease. In: DE JONG JM, ed. Handbook of
Clinical Neurology. Amsterdam: Elsevier Science Publishers,
1991;15(59):447–57.
37.
16. SMITH D, LUCAS S, JACEWICZ M. Multiple cerebral hemorrhages in HTLV-I-associated myelopathy. Neurology 1993;
43:412–14.
17. VERNANT J-C, BELLANCE R, BUISSON G et al. Peripheral
38.
neuropathies and myositis associated to HTLV-I infection in
Martinique. In: BLATTNER WA, ed. Human Retrovirology:
HTLV-I, New York: Raven Press Ltd., 1990;225–35.
18. IWASAKI Y. Pathology of chronic myelopathy associated
39.
with HTLV-I infection. J Neurol Sci 1990;96:103–23.
19. KIRA J, ITOYAMA Y, KOYANAGI Y et al. Presence of HTLV-I
proviral DNA in central nervous system of patients with
HTLV-I-associated myelopathy. Ann Neurol 1992;31:39–45. 40.
20. NAVARRO-ROMA ́ N L, CORBIN DOC, KATZ D et al. Human T- lymphotropic virus type I DNA in spinal cord of tropical
spastic paraparesis with concomitant human T-lymphotropic virus type I-negative Hodgkin's disease. Hum Pathol 41.
1994;25:1101–6.
21. MORITOYO T, REINHART TA, MORITOYO H et al. Human T- lymphotropic virus type I-associated myelopathy and tax
gene expression in CD4+ T lymphocytes. Ann Neurol
1996;40:84–90. 42.
22. CDC, USPHS. Guidelines for counseling persons infected
with human T lymphotropic virus type I (HTLV-I) and type
II (HTLV-II). Ann Int Med 1993;118:448–54. 43.
23. LAI RB, HENEINE W, RUDOLPH DL et al. Synthetic peptidebased immunoassays for distinguishing between human T- cell lymphotropic virus type I and type II infections in 44.
seropositive individuals. J Clin Microbiol 1991;29:2253–8.
24. IWASAKI Y, KINOSHITA M, IKEDA K, TAKAMIYA K. Human T-
